Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01168
Species: Homo sapiens
Position : chr17:38065200-38065700
Year: 2016
Title: 17q21 asthma-risk variants switch CTCF binding and regulate IL-2 production by T cells
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: asthma
PMID:  27848966
MONDO: MONDO:0004607
Tissue: Blood
Tissue Ontology ID: UBERON:0000178
Cell Source: B cells
CVCL ID:
Cell Type: B cell
Cell Ontology ID: CL:0000945
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: ChIP-seq, 4C-seq, RNA-seq, DNase-seq
Low Throughput Method: ChIP-qPCR, Allele-specific ChIP, RT-qPCR, siRNA knockdown, Flow cytometry, Cytokine ELISA, Sanger sequencing
About Target Gene
Target gene :
About TF
TF name : CTCF; IRF1; PAX4; TCF3
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 7 found
Enhancer ID Position Tissue Cell Disease
E_00821 chr17:38065000-38068000 Peripheral blood CD4-positive T cell --
E_01166 chr17:38065200-38065700 Blood CD4-positive T cell asthma
E_01167 chr17:38065200-38065700 Lymphoid tissue CD8-positive T cell asthma
E_01169 chr17:38065200-38065700 Blood NK cell asthma
E_01170 chr17:38065200-38065700 Blood T lymphoma cell asthma
E_00423 chr17:38065500-38067500 Blood CD4-positive T cell --
E_00424 chr17:38065500-38067500 Blood T lymphoma cell cutaneous T-cell lymphoma
Expression of Target Genes for the Enhancer